Observational study of the epidemiology and outcomes of vancomycin-resistant Enterococcus bacteraemia treated with newer antimicrobial agents.
about
New Insight on Epidemiology and Management of Bacterial Bloodstream Infection in Patients with Hematological MalignanciesDaptomycin for the treatment of bacteraemia due to vancomycin-resistant enterococciSystematic review and meta-analysis of linezolid versus daptomycin for treatment of vancomycin-resistant enterococcal bacteremiaDaptomycin versus linezolid for treatment of vancomycin-resistant enterococcal bacteremia: systematic review and meta-analysis.Treatment considerations in vancomycin-resistant enterococcal bacteremia: daptomycin or linezolid? A review.Impact of vancomycin resistance on mortality in neutropenic patients with enterococcal bloodstream infection: a retrospective study.Comparison of the Effectiveness and Safety of Linezolid and Daptomycin in Vancomycin-Resistant Enterococcal Bloodstream Infection: A National Cohort Study of Veterans Affairs PatientsRisk factors associated with linezolid-nonsusceptible enterococcal infections.Enterococcal bacteremia is associated with increased risk of mortality in recipients of allogeneic hematopoietic stem cell transplantationSystematic review and meta-analysis of linezolid and daptomycin for treatment of vancomycin-resistant enterococcal bloodstream infections.Vancomycin-resistant Enterococcus faecium Bacteremia in a tertiary care hospital: epidemiology, antimicrobial susceptibility, and outcome.Vancomycin-resistant enterococcal bacteremia pharmacotherapy.Therapeutic options for vancomycin-resistant enterococcal bacteremia.Enterococcal bloodstream infection. Design and validation of a mortality prediction rule.Secular Trends in Nosocomial Vancomycin-Resistant Enterococcal Bloodstream Infections Among United States Veterans Affairs Hospitals, Fiscal Years 2004 through 2014.Effect of Continuous and Sequential Therapy among Veterans Receiving Daptomycin or Linezolid for Vancomycin-Resistant Enterococcus faecium Bacteremia.Evaluation of standard- and high-dose daptomycin versus linezolid against vancomycin-resistant Enterococcus isolates in an in vitro pharmacokinetic/pharmacodynamic model with simulated endocardial vegetations.Risk factors for vancomycin-resistant enterococcus bacteremia and its influence on survival after allogeneic hematopoietic cell transplantation.Endocarditis caused by resistant enterococcus: an overview.Microbiological and clinical characteristics of vancomycin-resistant Enterococcus faecium bacteraemia in Taiwan: implication of sequence type for prognosis.Molecular epidemiology of vancomycin-resistant enterococcal bacteraemia: results from the Canadian Nosocomial Infection Surveillance Program, 1999-2009.
P2860
Q26799580-17C3741E-1E65-4AB3-A647-C7EC0F79DA99Q26851754-5DC43162-4A40-4319-B183-FEBB2C32B5ECQ28302184-92C3A59A-A9A1-4764-889F-B3E2C6CD7A25Q34728711-49E4C1C2-2A6F-4860-BDE5-2715D14FA543Q34871254-713C9F7F-A496-45D2-AAC4-23F3CAF930E3Q35027260-5812C5F1-14BE-4A57-901E-BEAE767A9D01Q35999714-4B744A40-C938-466C-A57F-E6A29D480E4BQ36818367-9E06FEEC-78B7-4BA6-A2E9-02B2468D6E52Q36853960-D779BBE2-7A04-4528-B4B6-D2B0152B81EAQ37263709-3FE86FDC-600D-4F9A-A7CC-D9145508C8D5Q37657769-EB45E342-27B0-4439-AB42-4828967AF474Q38263421-4BBF424A-EB46-4E7A-BD91-4D76EC227EE9Q38347869-4913CFD1-FFE3-433F-9400-BEFC85B16A6CQ40053444-F7D0FE1A-1A78-4A9F-921E-B9119F083ECEQ40141145-9F7A05F4-DA20-478D-9504-FA91840CF1DBQ40306161-ABC576CC-6954-4AD6-8519-1221CB554B78Q42189998-8086B73C-25E6-456F-AC5F-206D1D37EB24Q42202379-5D4D68A8-34FC-4426-947E-8C0570DFD5D7Q42259672-A09B6CD2-EE05-4374-9827-52BB09CDD993Q50943146-09295577-2AC7-4BE7-8275-8610B9136510Q54266977-16775874-BDF3-4923-B49D-4CAA385BA20F
P2860
Observational study of the epidemiology and outcomes of vancomycin-resistant Enterococcus bacteraemia treated with newer antimicrobial agents.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh
2010年學術文章
@zh-hant
name
Observational study of the epi ...... th newer antimicrobial agents.
@en
Observational study of the epi ...... th newer antimicrobial agents.
@nl
type
label
Observational study of the epi ...... th newer antimicrobial agents.
@en
Observational study of the epi ...... th newer antimicrobial agents.
@nl
prefLabel
Observational study of the epi ...... th newer antimicrobial agents.
@en
Observational study of the epi ...... th newer antimicrobial agents.
@nl
P2093
P2860
P1476
Observational study of the epi ...... th newer antimicrobial agents.
@en
P2093
J A McKinnell
J W Baddley
R M Shirley
P2860
P304
P356
10.1017/S0950268810002475
P577
2010-11-15T00:00:00Z